Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications.
Adoptive
CD8-Positive T-Lymphocytes
CTLA-4 Antigen
Immunotherapy
diagnostic imaging
positron emission tomography
programmed cell death 1 receptor
radioactive tracers
radionuclide imaging
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
06 Feb 2020
06 Feb 2020
Historique:
received:
18
12
2019
revised:
21
01
2020
accepted:
04
02
2020
entrez:
12
2
2020
pubmed:
12
2
2020
medline:
12
2
2020
Statut:
epublish
Résumé
Immunotherapy by using immune checkpoint inhibitors is a revolutionary development in oncology. Medical imaging is also impacted by this new therapy, particularly nuclear medicine imaging (also called radionuclide imaging), which uses radioactive tracers to visualize metabolic functions. Our aim was to review the current applications of nuclear medicine imaging in immunotherapy, along with their limitations, and the perspectives offered by this imaging modality.
Identifiants
pubmed: 32041105
pii: cancers12020371
doi: 10.3390/cancers12020371
pmc: PMC7072145
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Clin Oncol. 2018 Mar 20;36(9):850-858
pubmed: 29341833
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Lancet Oncol. 2018 Sep;19(9):1180-1191
pubmed: 30120041
Contrast Media Mol Imaging. 2018 Jun 6;2018:9257929
pubmed: 29983647
JCI Insight. 2018 Dec 6;3(23):
pubmed: 30518694
J Nucl Med. 2015 Aug;56(8):1258-64
pubmed: 25952734
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):930-939
pubmed: 30488098
Radiographics. 2015 Mar-Apr;35(2):424-37
pubmed: 25763727
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
Eur J Cancer. 2018 Sep;101:181-190
pubmed: 30077123
Theranostics. 2018 Nov 28;8(21):6070-6087
pubmed: 30613283
Eur J Nucl Med Mol Imaging. 2019 Nov 23;:
pubmed: 31760467
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Nucl Med. 2018 Feb;59(2):194-196
pubmed: 28970330
J Digit Imaging. 2019 Apr;32(2):241-250
pubmed: 30756268
Cancer. 2018 Jul 15;124(14):2906-2922
pubmed: 29671876
Genes Dev. 2018 Oct 1;32(19-20):1267-1284
pubmed: 30275043
Mol Clin Oncol. 2018 Sep;9(3):283-286
pubmed: 30155251
Cancer Lett. 2018 Feb 1;414:166-173
pubmed: 29155348
Leuk Lymphoma. 2019 Feb;60(2):367-375
pubmed: 30032683
Oncotarget. 2018 Jul 13;9(54):30268-30278
pubmed: 30100988
Target Oncol. 2018 Apr;13(2):113-123
pubmed: 29470785
Melanoma Res. 2019 Jun;29(3):318-321
pubmed: 30557217
Mol Imaging. 2017 Jan-Dec;16:1536012117718459
pubmed: 28707500
Cancers (Basel). 2019 Aug 29;11(9):
pubmed: 31470546
Trends Cancer. 2018 May;4(5):359-373
pubmed: 29709260
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Lung Cancer. 2019 Mar;129:41-47
pubmed: 30797490
J Nucl Med. 2019 Sep;60(9):1213-1220
pubmed: 30796165
Lung Cancer. 2018 May;119:71-77
pubmed: 29656756
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2310-2325
pubmed: 28815334
Blood. 2016 Nov 24;128(21):2489-2496
pubmed: 27574190
J Nucl Med. 2019 Mar;60(3):335-341
pubmed: 30413661
J Clin Oncol. 2017 Mar;35(7):785-792
pubmed: 28068177
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):238-250
pubmed: 30291373
J Nucl Med. 2019 Oct 18;:
pubmed: 31628220
Eur J Cancer. 2018 Jan;88:38-47
pubmed: 29182990
Nat Commun. 2018 Nov 7;9(1):4664
pubmed: 30405135
EJNMMI Res. 2019 Jan 29;9(1):8
pubmed: 30694399
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1954-61
pubmed: 27251642
J Nucl Med. 2018 Aug;59(8):1174-1182
pubmed: 29794226
Theranostics. 2018 Jun 7;8(13):3559-3570
pubmed: 30026866
Cancer Immunol Immunother. 2018 Aug;67(8):1261-1270
pubmed: 29872898
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Ann Transl Med. 2018 Jun;6(11):222
pubmed: 30023385
Br J Radiol. 2018 Apr;91(1084):20170457
pubmed: 29172675
Cancer Res. 2018 Oct 1;78(19):5706-5717
pubmed: 30115693
Ann Oncol. 2019 Mar 1;30(3):385-396
pubmed: 30657859
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):376-383
pubmed: 29124281
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):95-101
pubmed: 28831583
Oncoimmunology. 2019 Mar 6;8(5):e1580128
pubmed: 31069139
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1289-1296
pubmed: 29478079
Nat Rev Clin Oncol. 2019 Sep;16(9):563-580
pubmed: 31092901
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):695-706
pubmed: 26519292
Mol Cancer. 2018 Aug 23;17(1):129
pubmed: 30139382
PLoS One. 2018 Feb 15;13(2):e0192747
pubmed: 29447210
Clin Cancer Res. 2009 Dec 1;15(23):7412-20
pubmed: 19934295
Blood. 2020 Feb 20;135(8):523-533
pubmed: 31790142
Lancet Oncol. 2017 Mar;18(3):e143-e152
pubmed: 28271869
Melanoma Res. 2019 Apr;29(2):178-186
pubmed: 30653029
Nat Immunol. 2002 Jul;3(7):611-8
pubmed: 12087419
Sci Rep. 2018 Jan 8;8(1):105
pubmed: 29311707
EJNMMI Res. 2018 Aug 15;8(1):80
pubmed: 30112704
Cancer. 2019 Apr 15;125(8):1341-1349
pubmed: 30768786
J Clin Invest. 2019 Feb 1;129(2):616-630
pubmed: 30457978
J Nucl Med. 2018 Jan;59(1):15-24
pubmed: 28596157
Cancer Treat Rev. 2018 Nov;70:232-244
pubmed: 30308466
Nat Med. 2018 Dec;24(12):1852-1858
pubmed: 30478423
Ann Oncol. 2019 Jun 1;30(6):998-1004
pubmed: 30895304
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):848-854
pubmed: 30627815
Ann Oncol. 2018 Oct 1;29(10):2115-2120
pubmed: 30137228
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Immunotherapy. 2018 Jul;10(9):797-805
pubmed: 30008262
Radiat Oncol. 2018 May 31;13(1):102
pubmed: 29855323
Eur J Nucl Med Mol Imaging. 2019 Nov 21;:
pubmed: 31754795
Clin Cancer Res. 2013 Jul 15;19(14):3936-43
pubmed: 23743568
J Nucl Med. 2017 Sep;58(9):1421-1428
pubmed: 28360208
Radiographics. 2017 Nov-Dec;37(7):2132-2144
pubmed: 29131763
Leukemia. 2019 Apr;33(4):844-862
pubmed: 30700842
Cancer Immunol Res. 2013 Dec;1(6):365-72
pubmed: 24563870
Eur J Cancer. 2018 Jun;96:91-104
pubmed: 29698933
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):56-66
pubmed: 28828507
Cancer Immunol Immunother. 2019 Feb;68(2):297-303
pubmed: 30478475
JAMA Oncol. 2018 Nov 1;4(11):1543-1552
pubmed: 30193240
Clin Cancer Res. 2019 Feb 15;25(4):1196-1205
pubmed: 30327313
J Nucl Med. 2016 Oct;57(10):1607-1611
pubmed: 27230929
Cancer Immunol Res. 2015 Oct;3(10):1185-92
pubmed: 26100356
PLoS One. 2018 May 16;13(5):e0197472
pubmed: 29768501
Nat Immunol. 2013 Dec;14(12):1212-8
pubmed: 24240160
Clin Nucl Med. 2019 Apr;44(4):e272-e279
pubmed: 30688730
Am Soc Clin Oncol Educ Book. 2018 May 23;38:1008-1018
pubmed: 30231314